1. Resistencia antimicrobiana y mortalidad en pacientes con infección por Pseudomonas aeruginosa.
- Author
-
Mesinas Garrido, Mayte, Díaz Romero, Alberto, Alberti Minuto, Paolo, and López Vejar, César Emmanuel
- Abstract
OBJECTIVE: To determine antimicrobial susceptibility and mortality in patients with Pseudomonas aeruginosa infection. MATERIALS AND METHODS: An observational, transversal, descriptive and retrospective study was done to evaluate sensitivity pattern in Pseudomonas aeruginosa isolation; mortality on infected patients was also assessed. RESULTS: There were included 59 patients, the median age was 57 years (range 41 to 71 years), lung isolation was the most common in 26 cases; 48 cases of infection were hospital-acquired, 20 patients died; 32/59 patients received antibiotic treatment with activity against Pseudomonas and had a favorable outcome. Resistance to ceftazidime, amikacin, gentamicin, and ciprofloxacin was more common among those who died. Risk factors for mortality included SARS-CoV-2 infection, hospitalacquired, stay in intensive care unit, mechanical ventilation and treatment without coverage against Pseudomonas. CONCLUSIONS: In Pseudomonas aeruginosa infection, receiving ineffective antimicrobial treatment is the most important risk factor associated to death. Antimicrobial resistance showed no impact on outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF